Search results
Levosimendan Efficacy and Safety
Author(s):
Zoltán Papp
,
Piergiuseppe Agostoni
,
Julian Alvarez
,
et al
Added:
3 years ago
Article
Levosimendan in AHF and AdHF
Author(s):
Piergiuseppe Agostoni
,
Dimitrios T Farmakis
,
Jose M García-Pinilla
,
et al
Added:
3 years ago
Article
Inotropes in Acute Heart Failure
Author(s):
Vasiliki Bistola
,
Angelos Arfaras-Melainis
,
Eftihia Polyzogopoulou
,
et al
Added:
3 years ago
Article
Author(s):
Till Hauffe
,
Bernard Krüger
,
Dominique Bettex
,
et al
Added:
3 years ago
Shock in cardio-surgical intensive care unit (ICU) patients is a serious condition associated with a high morbidity and mortality.1,2 Prompt identification of the underlying condition and timely therapeutic interventions are key to reverse the shock state and to improve the patients’ outcome. Hence, the management during the first 6 hours is of paramount importance. This time period is also…
View more
Author(s):
Attilio Iacovoni
,
Emilia D’Elia
,
Mauro Gori
,
et al
Added:
3 years ago
Heart failure (HF) is a pandemic, chronic degenerative disease estimated to affect 38 million people worldwide, a number expected to increase with the ageing of the population.1 As a syndrome, it is associated with high mortality and morbidity, and consistently requires increasing resources. HF is the most frequent cause of hospitalisation in patients aged over 65 years, and hospitalised patients…
View more
Foreword
Author(s):
Andrew JS Coats
,
Giuseppe Rosano
Added:
3 years ago
Article
Author(s):
Barry Borlaug
Added:
3 years ago
For PH-HFpEF patients, the heart muscles are too weak to pump blood properly, despite the fact that the heart beats normally and is an area with no approved treatment options.
In this video, Dr Borlaug (Mayo Clinic, Rochester, US) discusses the primary results of the Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF (HELP) trial.
Questions:
1. What is the rationale behind this…
View more
Author(s):
Laura Kearney
,
Paul Wright
,
Sadeer Fhadil
,
et al
Added:
3 years ago
Postpartum cardiomyopathy (PPCM) is a diagnosis of exclusion, where patients present with heart failure secondary to left ventricular (LV) systolic dysfunction towards the end of pregnancy or in the months following delivery, with no other cause of heart failure identified.1 PPCM is relatively uncommon, affecting between one in 5,000 and one in 10,000 births;2 it is thought to be more prevalent…
View more
Author(s):
Ovidiu Chioncel
,
Sean P Collins
,
Andrew P Ambrosy
,
et al
Added:
3 years ago
Acute heart failure (AHF) is a heterogeneous clinical syndrome including diverse phenotypes sharing similar presenting signs and symptoms.1 The diversity of aetiologies and precipitants of HF and their specific pathophysiologic mechanisms, may result in distinct clinical profiles requiring specific treatment approaches.
Pulmonary oedema (PO) is a common manifestation of AHF associated with a…
View more
Milton Packer
Research Area(s) / Expertise:
Author